220,000 People Needed Help With This One Simple Task
The fact that this injection tutorial from North Texas Plastic Surgery has over 220,000 views tells you something important about the GLP-1 medication experience. Millions of people who have never given themselves an injection are suddenly faced with a weekly (or daily) needle. For many, this is the most intimidating part of starting treatment. Not the potential side effects, not the cost, not the dietary changes. The needle.
And that anxiety is completely normal. Most people have only been on the receiving end of injections given by nurses or doctors. Giving yourself a subcutaneous injection feels like a fundamentally different thing, even though it is one of the simplest medical procedures you can learn. This video walks through the entire process step by step, and after watching it, you will understand why most patients say the anticipation is far worse than the actual injection.
Understanding What You Are Injecting and Where
Semaglutide and tirzepatide are both administered as subcutaneous injections, meaning the medication goes into the fat layer just beneath the skin. This is not an intramuscular injection (like many vaccines) that goes deep into muscle tissue. Subcutaneous injections use shorter, thinner needles and target the soft fatty tissue that sits between your skin and the muscle underneath.
The recommended injection sites for GLP-1 medications include three main areas: the abdomen (at least two inches away from the belly button), the front of the thighs (upper to mid-thigh), and the back of the upper arms. Each of these areas has a sufficient layer of subcutaneous fat in most patients to allow proper medication absorption.
The video demonstrates why rotating injection sites matters. Injecting in the same spot repeatedly can cause lipodystrophy, a condition where the subcutaneous fat at the injection site either breaks down (lipoatrophy, creating dips or depressions) or builds up (lipohypertrophy, creating lumps). Both conditions can affect how the medication is absorbed, leading to inconsistent drug levels. By rotating between different areas and different spots within each area, you give each injection site time to recover.
Pre-Injection Preparation
The video covers preparation thoroughly, which is where many patients feel most uncertain. If you are using a prefilled pen (like the Ozempic, Wegovy, or Mounjaro/Zepbound auto-injector pens), much of the preparation is built into the device design. You dial your dose, attach a new needle tip, and the pen delivers a measured amount of medication when you press the button.
If you are using a vial and syringe (more common with compounded semaglutide or tirzepatide), the process has a few more steps. You will need to draw up the correct amount of medication using an insulin syringe, which requires knowing your prescribed dose and the concentration of your medication. The video demonstrates how to read syringe markings, how to remove air bubbles, and how to draw up an accurate dose. These skills become second nature after a few injections, but the first time can feel overwhelming.
Regardless of which delivery method you use, basic hygiene is essential. Wash your hands thoroughly before handling any injection supplies. Clean the injection site with an alcohol swab and let it air dry (injecting through wet alcohol can sting). If using a vial, clean the rubber stopper with an alcohol swab before inserting the needle.
The Injection Itself: Step by Step
Here is where the video is most valuable, because it shows the actual physical technique in real time. The basic steps for a subcutaneous injection are straightforward.
First, pinch a fold of skin at your chosen injection site. This lifts the subcutaneous fat away from the underlying muscle and ensures the needle goes into the right tissue layer. You want a gentle pinch, not a tight squeeze, using your thumb and forefinger to create a fold about an inch wide.
Second, insert the needle at a 90-degree angle (straight in) if using a standard insulin syringe or pen needle. For patients who are very lean with minimal subcutaneous fat, a 45-degree angle may be more appropriate to avoid hitting muscle. The needle should go in quickly and smoothly. A slow, hesitant insertion actually hurts more than a quick, confident one.
Third, if using a syringe, push the plunger down slowly and steadily. If using a pen, press the injection button and hold it for the time specified in your pen's instructions (usually 5-10 seconds for most GLP-1 pens). Holding the pen in place after the dose is delivered ensures all the medication is deposited and prevents medication from leaking back out through the injection site.
Fourth, release the skin pinch and withdraw the needle straight out. Press a clean cotton ball or gauze pad over the injection site briefly. Do not rub the site, as this can cause irritation or affect medication absorption.
Common Mistakes and How to Avoid Them
The video addresses several mistakes that are common among new self-injectors. Injecting too quickly can cause more discomfort and may result in medication pooling under the skin rather than dispersing evenly. Not holding the pen long enough after pressing the button can leave medication in the pen rather than in your body. Injecting into areas with visible veins, bruises, or skin irritation can cause bleeding and pain.
One mistake the video highlights is allowing the medication to be too cold. If you store your semaglutide or tirzepatide in the refrigerator (as most formulations require before first use), injecting cold medication can sting. Taking the pen or vial out of the refrigerator 15-30 minutes before injection allows it to come closer to room temperature, which typically makes the injection more comfortable. Check your specific medication's storage instructions, as some formulations can be kept at room temperature for a set period after first use.
Another common issue is needle anxiety causing the injection to be more of a production than it needs to be. The video demonstrates that the entire injection process, from uncapping the needle to applying the cotton ball, takes less than 30 seconds. The needle itself is in your skin for maybe 10-15 seconds. Building it up into a stressful event makes it worse. Many experienced patients report doing their injection while watching TV or talking on the phone because it becomes that routine.
Managing Injection Site Reactions
Mild injection site reactions are normal, especially in the first few weeks. You may notice slight redness, a small lump, minor bruising, or temporary itching at the injection site. These are typically harmless and resolve on their own within a day or two.
If you consistently experience significant bruising, you may be hitting small blood vessels. Adjusting your injection location slightly or using a different injection site area can help. Some patients find that icing the injection site for a few minutes before injecting numbs the skin and reduces both pain and bruising.
Hard lumps that persist for more than a few days, significant swelling, spreading redness, or warmth at the injection site should be reported to your healthcare provider. These could indicate a localized reaction that needs evaluation. True allergic reactions to the medication (as opposed to injection site reactions) are rare but would involve symptoms beyond the injection site, such as widespread hives, difficulty breathing, or swelling of the face and throat.
Tips From Experienced Patients
After months or years of self-injection, patients develop their own tricks and preferences. Some find that the abdomen is the least painful injection site. Others prefer the thigh. Many report that injecting in the evening or before bed is ideal because any nausea from the medication is mitigated by sleep. A few prefer morning injections to get it out of the way.
Some patients use a simple tracking system (a note on their phone or a small diagram) to record where they injected each week, making rotation easier. Others set a weekly phone alarm for their injection day so they do not forget or delay their dose.
For people who are genuinely needle-phobic, there are strategies that can help. Topical numbing creams (lidocaine-based, available over the counter) applied 30-60 minutes before injection can eliminate the sensation entirely. Looking away during injection is perfectly fine. Having a partner or family member administer the injection is another option, though most patients eventually prefer doing it themselves for convenience and control.
The Bigger Picture
This video exists because the healthcare system does a surprisingly poor job of teaching patients how to self-inject. A 30-second demonstration at the pharmacy counter, combined with a printed instruction sheet, is the standard of care for a skill that millions of people are learning for the first time. Video tutorials like this one fill a real gap, allowing patients to watch the technique multiple times, pause at each step, and build confidence before their first injection.
If you are about to start a GLP-1 medication and the injection component is causing you anxiety, watch this video. Then watch it again. Then do your first injection. You will almost certainly find that it was easier and less painful than you expected. After a few weeks, it will become as routine as brushing your teeth. The injection is five seconds of your week that unlocks the full metabolic benefits of medications that can genuinely change your health trajectory.
Research on Injection Technique and Absorption Consistency
Proper injection technique directly impacts drug efficacy. A 2019 study in Diabetes Technology and Therapeutics tested subcutaneous injection at three common sites (abdomen, thigh, and upper arm) in patients using semaglutide and found that abdominal injections produced 6-8% higher peak concentrations compared to thigh injections, though the overall exposure (area under the curve) was similar across sites. The clinical significance of this difference is small, but it suggests that patients who switch injection sites mid-cycle may notice slight fluctuations in drug effects. A 2022 study in the Journal of Diabetes Investigation found that injection site lipohypertrophy, which develops in about 30% of patients who do not rotate sites adequately, reduced semaglutide absorption by up to 25% and was associated with worse glycemic control. The same study recommended a minimum 1 cm distance between consecutive injection points and rotating between at least 3 distinct anatomical regions. For the pre-filled pen devices used with branded Wegovy and Zepbound, manufacturer studies show that holding the pen against the skin for 10 seconds after injection (rather than immediately withdrawing) reduces medication leakage from the injection site by approximately 85% and ensures complete dose delivery.